Filter Results:
(143)
Show Results For
- All HBS Web
(143)
- News (61)
- Research (35)
- Events (4)
- Multimedia (4)
- Faculty Publications (26)
Show Results For
- All HBS Web
(143)
- News (61)
- Research (35)
- Events (4)
- Multimedia (4)
- Faculty Publications (26)
- 24 Jun 2014
- News
Amy Cuddy - Social Psychologist, Dancer
- 26 Nov 2012
- News
“Indispensable: When Leaders Really Matter”
Kyle R. Myers
Kyle Myers is an associate professor of business administration in the Technology and Operations Management unit. He teaches the first-year Technology and Operations Management course.
Professor Myers studies the economics of innovation. His research is at... View Details
- 11 Feb 2013
- News
Thorny research problems, solved by crowdsourcing
- June 2004 (Revised May 2005)
- Case
Judah Folkman and the War on Cancer
Judah Folkman, professor in the Division of Vascular Biology at Children's Hospital in Boston, is considering how best to advance the research in his lab in an era where biomedical research has gotten more interdisciplinary and collaborative. Specifically, Folkman has... View Details
Keywords: Conflict of Interests; Leadership; Research; Personal Development and Career; Health Care and Treatment; Collaborative Innovation and Invention; Biotechnology Industry; Health Industry; Boston
West, Jonathan, Ambuj Sagar, and Mona Ashiya. "Judah Folkman and the War on Cancer." Harvard Business School Case 604-091, June 2004. (Revised May 2005.)
- 15 Sep 2020
- Blog Post
One Month into the New MS/MBA Biotech
Harvard’s new MS/MBA Biotechnology: Life Sciences joint degree program confers an MBA from Harvard Business School and a Master of Science from the Graduate School of Arts and Sciences and Harvard Medical School in the Harvard Department of Stem Cell and Regenerative... View Details
- February 2010
- Case
Amyris Biotechnologies: Commercializing Biofuel
By: Gary P. Pisano and Alison Berkley Wagonfeld
In 2009, Amyris Biotechnologies was building a plant in Brazil that used synthetic biology to convert sugarcane into both renewable fuels and renewable chemicals. The Amyris' marketing team was investigating the commercial interest for both types of products, while the... View Details
Keywords: Renewable Energy; Chemicals; Risk Management; Product Marketing; Product Development; Production; Environmental Sustainability; Commercialization; Biotechnology Industry; Brazil
Pisano, Gary P., and Alison Berkley Wagonfeld. "Amyris Biotechnologies: Commercializing Biofuel." Harvard Business School Case 610-031, February 2010.
Paul A. Gompers
Paul Gompers, Professor of Business Administration at the Harvard Business School, specializes in research on financial issues related to start-up, high growth, and newly public companies. Professor Gompers has an appointment in both the View Details
- October 2019 (Revised November 2019)
- Case
C16 Biosciences: Lab-Grown Palm Oil
By: Jeffrey J. Bussgang and Olivia Hull
Synthetic biology start-up C16 Biosciences wants to solve a big problem: replace palm oil, a major contributor to deforestation and climate change, with a lab-grown substitute. CEO Shara Ticku has ambitious plans to supply her lab-grown palm oil to food manufacturers,... View Details
Keywords: Science-Based Business; Environmental Sustainability; Social Entrepreneurship; Product Development; Product Positioning; Venture Capital; Strategy; Decision Making; Food and Beverage Industry; Consumer Products Industry
Bussgang, Jeffrey J., and Olivia Hull. "C16 Biosciences: Lab-Grown Palm Oil." Harvard Business School Case 820-008, October 2019. (Revised November 2019.)
- November 2024
- Supplement
AlphaGo (C): Birth of a New Intelligence
By: Shikhar Ghosh and Shweta Bagai
This case, the final of a three-part series, explores DeepMind's pivotal transition from mastering games to solving real-world scientific challenges. In December 2020, DeepMind's AI system AlphaFold 2 achieved a breakthrough by solving protein folding—a 50-year-old... View Details
Keywords: Autonomy; Deep Learning; Drug Discovery; Healthcare Innovation; Neural Networks; Scientific Research; Technology Startup; AI and Machine Learning; Technological Innovation; Research and Development; Business Model; Business Strategy; Open Source Distribution; Technology Industry; United States
Ghosh, Shikhar, and Shweta Bagai. "AlphaGo (C): Birth of a New Intelligence." Harvard Business School Supplement 825-075, November 2024.
- March 2011 (Revised June 2012)
- Case
Office of Technology Transfer - Shanghai Institutes for Biological Sciences
By: Willy Shih, Sen Chai, Kamen Bliznashki and Courtney Hyland
Gordon Zong is trying to teach Chinese universities and research institutes how to do effective technology transfer and IP licensing, but he is trying to do it in an environment with weak property rights and an underdeveloped support infrastructure. As the managing... View Details
Keywords: Multinational Firms and Management; Patents; Knowledge Management; Law Enforcement; Business and Government Relations; Research and Development; Biotechnology Industry; Pharmaceutical Industry; China
Shih, Willy, Sen Chai, Kamen Bliznashki, and Courtney Hyland. "Office of Technology Transfer - Shanghai Institutes for Biological Sciences." Harvard Business School Case 611-057, March 2011. (Revised June 2012.)
- April 2002
- Case
In vivo to in vitro to in silico: Coping with Tidal Waves of Data at Biogen
By: Juan Enriquez-Cabot, Gary P. Pisano and Gaye Bok
Biogen is a successful biotech company facing a critical juncture. CEO John Mullen ponders how technological changes introduced into the research function will shape larger corporate decisions. This world in which biotechnology companies operated had changed... View Details
Keywords: Change; Decisions; Product Development; Research and Development; Expansion; Technology; Biotechnology Industry
Enriquez-Cabot, Juan, Gary P. Pisano, and Gaye Bok. "In vivo to in vitro to in silico: Coping with Tidal Waves of Data at Biogen." Harvard Business School Case 602-122, April 2002.
David Ager
David Ager is a Senior Lecturer in Executive Education. He engages CEOs, CHROs, and their teams to design and deliver customized executive development experiences for executive, senior and high potential leaders. The companies hail from diverse sectors including... View Details
- Web
Curriculum | MBA
likely in the life sciences or biotech space. Capstone Overview First Year AUGUST Harvard Business School Online CORe Harvard Business School NextGen Biotechnology Harvard Department of Stem Cell and Regenerative Biology FALL TERM Data... View Details
- Web
Admissions & Financial Aid | MBA
experience. If you are unsure whether your background has prepared you sufficiently, consider your familiarity with the topics covered in Molecular Biology of the Cell by Alberts et al. Students are expected to be knowledgeable with that... View Details
- Web
Faculty & Advisors | MBA
M.D. MS/MBA Program Faculty Co-Chair for MS Professor of Stem Cell and Regenerative Biology at Harvard University, Chief of Pathways Consult Service at Massachusetts General Hospital Douglas Melton, Ph.D. MS/MBA Program Faculty Co-Chair... View Details
- Web
Live from Klarman Hall - Alumni
changed by AI and the core processes of sciences, like biology and physics, can be accelerated to where we could get a hundred years of development in a decade? What is likely to change? What will remain the same? How should we think... View Details